GlassScriptPhysician profile
Susan Lee
NPI 1306200175
$4,071.56
in general payments reported to CMS, 2019-2025
21 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2021: $23.27 · 2022: $132 · 2023: $46.00 · 2024: $3,483 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $801.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,208.45 | 2019-2024 | |
| Abbvie INC. | $167.10 | 2021-2025 | |
| Hologic Sales and Service, LLC | $74.68 | 2024 | Myosure Tissue Removal Device, Thinprep 2000 Processor, Aptima |
| Exeltis, USA INC. | $69.30 | 2024-2025 | Slynd |
| Boston Scientific Corporation | $60.78 | 2019 | |
| Biogen, INC. | $55.17 | 2025 | Zurzuvae |
| Medtronic, INC. | $53.39 | 2022 | |
| Organon LLC | $47.84 | 2024-2025 | Jada System, Nexplanon |
| Shield Therapeutics INC | $46.14 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $39.68 | 2024-2025 | Gardasil 9, Gardasil, Enflonsia |
| Mayne Pharma Commercial LLC | $37.07 | 2024 | |
| Davol INC. | $31.84 | 2023 | Arista Ah Flexitip |
| Bayer Healthcare Pharmaceuticals INC. | $30.30 | 2024 | |
| Coopersurgical, INC. | $24.38 | 2024 | Paragard T 380a |
| Evofem Biosciences, INC. | $23.39 | 2025 | Phexxi, Solosec, Phexx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $19.50 | 2025 | |
| Lsi Solutions INC | $18.80 | 2025 | Running Device, Ti-Knot, Fornisee |
| Pfizer INC. | $18.61 | 2024 | |
| Smith+Nephew, INC. | $15.84 | 2024 | Pico 14, Pico 7 |
| Astellas Pharma US INC | $15.39 | 2022 | |
| Lilly USA, LLC | $13.91 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.